National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1000251

History of Changes from the VAERS Wayback Machine

First Appeared on 2/12/2021

VAERS ID: 1000251
VAERS Form:2
Age:
Sex:Female
Location:Foreign
Vaccinated:2021-01-13
Onset:2021-01-20
Submitted:0000-00-00
Entered:2021-02-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other      Purchased by: ??
Symptoms: Cardiac failure, Cardiovascular disorder, Death, Pulmonary oedema, General physical health deterioration

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2021-01-20
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: LIXIANA; BURINEX; ESCITALOPRAM; AMLOR
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Hypertension; Osteoporosis; Comments: Hypertension, Osteoporosis
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': BEPFIZER INC2021088938

Write-up: General physical health deterioration; Cardiac failure; Lung edema; Cardiovascular disorder; This is a spontaneous report downloaded from the Medicines Agency (MA) WEB BE-FAMHP-DHH-N2021-75687. A contactable physician reported that a 85 years old female patient received first dose BNT162B2 (COMIRNATY), via an unspecified route of administration on 13Jan2021 at single dose for COVID-19 vaccination. The medical history included hypertension, osteoporosis. Concomitant drugs were escitalopram (strength 10 mg), bumetanide (BURINEX, strength 1 mg), edoxaban tosilate (LIXIANA, strength 60 mg) and amlodipine besilate(AMLOR, strength 10 mg).On 20Jan2021 the patient suffered from cardiovascular disorder, lung edema, cardiac failure and general physical health deterioration during treatment with BNT162B2. The patient died on 20Jan2021. It''s unknown if an autopsy was performed. The cause of death was cardiovascular disorder, lung edema, cardiac failure and general physical health deterioration. The outcome of events was fatal. Reporter Comment: no really obvious side effects after vaccination. earlier further deterioration (so this already deteriorated before vaccination) No follow-up attempts are possible. No further information is expected.; Reporter''s Comments: no really obvious side effects after vaccination. earlier further deterioration (so this already deteriorated before vaccination); Reported Cause(s) of Death: General physical health deterioration; Cardiac failure; Lung edema; Cardiovascular disorder


Changed on 5/7/2021

VAERS ID: 1000251 Before After
VAERS Form:2
Age:
Sex:Female
Location:Foreign
Vaccinated:2021-01-13
Onset:2021-01-20
Submitted:0000-00-00
Entered:2021-02-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other      Purchased by: ??
Symptoms: Cardiac failure, Cardiovascular disorder, Death, Pulmonary oedema, General physical health deterioration

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2021-01-20
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: LIXIANA; BURINEX; ESCITALOPRAM; AMLOR
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Hypertension; Osteoporosis; Comments: Hypertension, Osteoporosis
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': BEPFIZER INC2021088938

Write-up: General physical health deterioration; Cardiac failure; Lung edema; Cardiovascular disorder; This is a spontaneous report downloaded from the Medicines Agency (MA) WEB BE-FAMHP-DHH-N2021-75687. A contactable physician reported that a 85 years old female patient received first dose BNT162B2 (COMIRNATY), via an unspecified route of administration on 13Jan2021 at single dose for COVID-19 vaccination. The medical history included hypertension, osteoporosis. Concomitant drugs were escitalopram (strength 10 mg), bumetanide (BURINEX, strength 1 mg), edoxaban tosilate (LIXIANA, strength 60 mg) and amlodipine besilate(AMLOR, strength 10 mg).On 20Jan2021 the patient suffered from cardiovascular disorder, lung edema, cardiac failure and general physical health deterioration during treatment with BNT162B2. The patient died on 20Jan2021. It''s unknown if an autopsy was performed. The cause of death was cardiovascular disorder, lung edema, cardiac failure and general physical health deterioration. The outcome of events was fatal. Reporter Comment: no really obvious side effects after vaccination. earlier further deterioration (so this already deteriorated before vaccination) No follow-up attempts are possible. No further information is expected.; Reporter''s Comments: no really obvious side effects after vaccination. earlier further deterioration (so this already deteriorated before vaccination); Reported Cause(s) of Death: General physical health deterioration; Cardiac failure; Lung edema; Cardiovascular disorder


Changed on 5/14/2021

VAERS ID: 1000251 Before After
VAERS Form:2
Age:
Sex:Female
Location:Foreign
Vaccinated:2021-01-13
Onset:2021-01-20
Submitted:0000-00-00
Entered:2021-02-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other      Purchased by: ??
Symptoms: Cardiac failure, Cardiovascular disorder, Death, Pulmonary oedema, General physical health deterioration

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2021-01-20
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: LIXIANA; BURINEX; ESCITALOPRAM; AMLOR
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Hypertension; Osteoporosis; Comments: Hypertension, Osteoporosis
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': BEPFIZER INC2021088938

Write-up: General physical health deterioration; Cardiac failure; Lung edema; Cardiovascular disorder; This is a spontaneous report downloaded from the Medicines Agency (MA) WEB BE-FAMHP-DHH-N2021-75687. A contactable physician reported that a 85 years old female patient received first dose BNT162B2 (COMIRNATY), via an unspecified route of administration on 13Jan2021 at single dose for COVID-19 vaccination. The medical history included hypertension, osteoporosis. Concomitant drugs were escitalopram (strength 10 mg), bumetanide (BURINEX, strength 1 mg), edoxaban tosilate (LIXIANA, strength 60 mg) and amlodipine besilate(AMLOR, strength 10 mg).On 20Jan2021 the patient suffered from cardiovascular disorder, lung edema, cardiac failure and general physical health deterioration during treatment with BNT162B2. The patient died on 20Jan2021. It''s unknown if an autopsy was performed. The cause of death was cardiovascular disorder, lung edema, cardiac failure and general physical health deterioration. The outcome of events was fatal. Reporter Comment: no really obvious side effects after vaccination. earlier further deterioration (so this already deteriorated before vaccination) No follow-up attempts are possible. No further information is expected.; Reporter''s Comments: no really obvious side effects after vaccination. earlier further deterioration (so this already deteriorated before vaccination); Reported Cause(s) of Death: General physical health deterioration; Cardiac failure; Lung edema; Cardiovascular disorder

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1000251&WAYBACKHISTORY=ON

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166